SPOTLIGHT: IntraBiotics closes shop

IntraBiotics was taken over by a management firm after the company's remaining employees were let go. The company has been a shell of its former self since its lead product failed a clinical trial a year ago. Article

Suggested Articles

Californian RNA biotech Arrowhead will lose its COO and R&D head from next year but is hiring a new CMO and CSO to help steady its research exec team.

The biotech began testing the small molecule in a phase 3 trial of heavily pretreated small cell lung cancer patients late last year. 

Roche is spending up to $1.4 billion to snap up a scarring-focused biotech, nabbing an FDA breakthrough-tagged therapy in the process.